Novel perspectives on the hepatitis B virus vaccine in the chronic kidney disease population.

CONCLUSIONS: The immunogenicity of HBV vaccines in patients with CKD is suboptimal but novel technologies promise to give better results in the near future. PMID: 26821784 [PubMed - as supplied by publisher]
Source: The International Journal of Artificial Organs - Category: Transplant Surgery Authors: Tags: Int J Artif Organs Source Type: research